高级检索
当前位置: 首页 > 详情页

Chronic effects of different non-esterified fatty acids on pancreatic islets of rats

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Affiliated Hosp 4, Dept Endocrinol, Shijiazhuang 050011, Hebei, Peoples R China [2]Peking Univ, Sch Med, Dept Hlth Sci, Beijing, Peoples R China [3]Yamanashi Hlth Hosp, Yamanashi, Japan
出处:
ISSN:

关键词: non-esterified fatty acids pancreatic islet insulin secretion glucose intolerance pyruvate dehydrogenase

摘要:
Aims: The aim of this study was to examine the chronic effects of different non-esterified fatty acids (NEFA) on insulin secretion by pancreatic islets of normal Wistar rats in vitro. Methods: Pancreatic islets were isolated from normal Wistar rats, and were incubated with 0.2, 0.4, or 0.8 mmol/L palmitate (Cl 6:0), stearate (Cl 8:0), oleate (Cl 8: 1), or linoleate (Cl 8:2) for 24 h, then the insulin secretion and pyruvate dehydrogenase (PDH) activity were examined. Results: Neither islet insulin content nor islet DNA content differed among islets incubated with each kind of NEFA. Compared with control, linoleate significantly inhibited glucose-stimulated insulin secretion (GSIS) and PDH activity at each concentration (p < 0.05), while others inhibited GSIS and PDH activity significantly only at 0.4 and 0.8 mmol/L (p < 0.05). There was no significant difference in GSIS and PDH activity among islets pretreated by palmitate, stearate, and oleate at the same concentration (p > 0.05). However, linoleate decreased GSIS more than others at the same concentration (p < 0.05), while linoleate (0.4 or 0.8 mmol/L) inhibited PDH activity more than others at the same concentration (p < 0.05). Conclusions: Elevation of palmitate, stearate, oleate or linoleate decreases the beta-cell secretory response to glucose, through inhibiting PDH activity. Linoleate exerts more negative effect on GSIS than other NEFA.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2006]版:
大类 | 4 区 医学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
JCR分区:
出版当年[2006]版:
Q3 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2006版] 出版当年五年平均 出版前一年[2005版] 出版后一年[2007版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Affiliated Hosp 4, Dept Endocrinol, Shijiazhuang 050011, Hebei, Peoples R China [*1]Department of Endocrinology, The 4th Affiliated Hospital, HeBei Medical University, ShiJiazhuang, HeBei, 050011, China
通讯作者:
通讯机构: [1]Hebei Med Univ, Affiliated Hosp 4, Dept Endocrinol, Shijiazhuang 050011, Hebei, Peoples R China [*1]Department of Endocrinology, The 4th Affiliated Hospital, HeBei Medical University, ShiJiazhuang, HeBei, 050011, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号